{"resultsPerPage":1,"startIndex":0,"totalResults":1,"format":"NVD_CVE","version":"2.0","timestamp":"2026-05-11T19:11:54.204","vulnerabilities":[{"cve":{"id":"CVE-2020-12040","sourceIdentifier":"ics-cert@hq.dhs.gov","published":"2020-06-29T14:15:11.677","lastModified":"2024-11-21T04:59:09.957","vulnStatus":"Modified","cveTags":[],"descriptions":[{"lang":"en","value":"Sigma Spectrum Infusion System v's6.x (model 35700BAX) and Baxter Spectrum Infusion System Version(s) 8.x (model 35700BAX2) at the application layer uses an unauthenticated clear-text communication channel to send and receive system status and operational data. This could allow an attacker that has circumvented network security measures to view sensitive non-private data or to perform a man-in-the-middle attack."},{"lang":"es","value":"Sigma Spectrum Infusion System versiones v's6.x (modelo 35700BAX) y Baxter Spectrum Infusion System versiones 8.x (modelo 35700BAX2), en la capa de aplicación utilizan un canal de comunicación de texto sin cifrar no autenticado para enviar y recibir el estado del sistema y los datos operativos. Esto podría permitir a un atacante que haya eludido las medidas de seguridad de la red visualizar datos confidenciales no privados o llevar a cabo un ataque  de tipo man-in-the-middle"}],"metrics":{"cvssMetricV31":[{"source":"nvd@nist.gov","type":"Primary","cvssData":{"version":"3.1","vectorString":"CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H","baseScore":9.8,"baseSeverity":"CRITICAL","attackVector":"NETWORK","attackComplexity":"LOW","privilegesRequired":"NONE","userInteraction":"NONE","scope":"UNCHANGED","confidentialityImpact":"HIGH","integrityImpact":"HIGH","availabilityImpact":"HIGH"},"exploitabilityScore":3.9,"impactScore":5.9}],"cvssMetricV2":[{"source":"nvd@nist.gov","type":"Primary","cvssData":{"version":"2.0","vectorString":"AV:N/AC:L/Au:N/C:P/I:N/A:N","baseScore":5.0,"accessVector":"NETWORK","accessComplexity":"LOW","authentication":"NONE","confidentialityImpact":"PARTIAL","integrityImpact":"NONE","availabilityImpact":"NONE"},"baseSeverity":"MEDIUM","exploitabilityScore":10.0,"impactScore":2.9,"acInsufInfo":false,"obtainAllPrivilege":false,"obtainUserPrivilege":false,"obtainOtherPrivilege":false,"userInteractionRequired":false}]},"weaknesses":[{"source":"ics-cert@hq.dhs.gov","type":"Secondary","description":[{"lang":"en","value":"CWE-319"}]},{"source":"nvd@nist.gov","type":"Primary","description":[{"lang":"en","value":"CWE-319"}]}],"configurations":[{"operator":"AND","nodes":[{"operator":"OR","negate":false,"cpeMatch":[{"vulnerable":true,"criteria":"cpe:2.3:o:baxter:sigma_spectrum_infusion_system_firmware:*:*:*:*:*:*:*:*","versionStartIncluding":"6.0","versionEndIncluding":"6.05","matchCriteriaId":"0FCC49AB-B0AD-44FF-ACEB-3C26EA4F2C3C"},{"vulnerable":true,"criteria":"cpe:2.3:o:baxter:sigma_spectrum_infusion_system_firmware:8.0:*:*:*:*:*:*:*","matchCriteriaId":"72D0F7CB-3D24-4A8D-826D-ACB20ACBEB1C"}]},{"operator":"OR","negate":false,"cpeMatch":[{"vulnerable":false,"criteria":"cpe:2.3:h:baxter:sigma_spectrum_infusion_system:-:*:*:*:*:*:*:*","matchCriteriaId":"49E25260-EC14-4E98-A86B-CBBE47E26AE5"}]}]}],"references":[{"url":"https://www.us-cert.gov/ics/advisories/icsma-20-170-04","source":"ics-cert@hq.dhs.gov","tags":["Third Party Advisory","US Government Resource"]},{"url":"https://www.us-cert.gov/ics/advisories/icsma-20-170-04","source":"af854a3a-2127-422b-91ae-364da2661108","tags":["Third Party Advisory","US Government Resource"]}]}}]}